EZH2 anticorps (N-Term) (FITC)
Aperçu rapide pour EZH2 anticorps (N-Term) (FITC) (ABIN1894420)
Antigène
Voir toutes EZH2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- Human EZH2.
-
Purification
- Protein G purified
-
Immunogène
-
KLH-conjugated synthetic peptide from the N-terminal region of human EZH2.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, no preservatives added
-
Agent conservateur
- Without preservative
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Date de péremption
- 6 months
-
-
- EZH2 (Enhancer of Zeste Homolog 2 (EZH2))
-
Autre désignation
- EZH2
-
Sujet
-
Name/Gene ID: EZH2
Synonyms: EZH2, ENX1, Enhancer of zeste homolog 2, KMT6, KMT6A, Lysine N-methyltransferase 6, WVS2, Enhancer of zeste, ENX-1 -
ID gène
- 2146
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Regulation of Muscle Cell Differentiation
Antigène
-